DOI QR코드

DOI QR Code

A Review of Clinical Studies of Chinese Medicine Treatment of Polycystic Kidney Disease Using the CNKI Database

다낭신의 중의치료에 대한 임상연구 동향 - CNKI검색을 중심으로

  • Ju, Ah-ra (Dept. of Oriental Internal Medicine, Bu-Cheon Jaseng Hospital of Oriental Medicine) ;
  • Park, Mi-so (Dept. of Oriental Internal Medicine, Bu-Cheon Jaseng Hospital of Oriental Medicine) ;
  • Choi, Yo-sup (Dept. of Oriental Internal Medicine, Bu-Cheon Jaseng Hospital of Oriental Medicine) ;
  • Choo, Won-jung (Dept. of Oriental Internal Medicine, Bu-Cheon Jaseng Hospital of Oriental Medicine) ;
  • Baek, Hye-kyung (Dept. of Acupuncture and Moxibustion, Bu-Cheon Jaseng Hospital of Oriental Medicine) ;
  • Park, Mu-jin (Dept. of Clinical Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University)
  • 주아라 (부천자생한방병원 한방내과) ;
  • 박미소 (부천자생한방병원 한방내과) ;
  • 최요섭 (부천자생한방병원 한방내과) ;
  • 추원정 (부천자생한방병원 한방내과) ;
  • 백혜경 (부천자생한방병원 침구과) ;
  • 박무진 (경희대학교 대학원 한의과대학 임상한의학과)
  • Received : 2021.04.07
  • Accepted : 2021.06.28
  • Published : 2021.06.30

Abstract

Objective: This research reviews and investigates the trends in recent clinical studies of polycystic kidney disease (PKD) in China. Method: We searched for clinical studies discussing Oriental medicine-based treatments for PKD in the China National Knowledge Infrastructure (CNKI) database. Thirteen clinical articles published from 2001 to 2019 were analyzed. The search focused on the authors, publication year, type of study, purposes of study, method and duration of treatment, evaluation criteria, and results of the selected articles. Results: Of the articles from the database, 9 case series and 4 randomized controlled trials (RCTs) were analyzed. Ten articles used herbal medicine; 4 used herbal medicine for external use. Gamigyejibokryeong-hwan was the most common herbal prescription. The most frequently used herb was Polia Sclerotium (茯苓), and Cnidii Rhizoma (川芎) was employed in all the external uses. All 13 studies confirmed the efficacy of Oriental medicine treatments. Conclusion: 1. Scientifically designed and more varied clinical studies are required to develop treatments for PKD. 2. The current study could be used as basic data in future clinical studies on treatment and further studies of PKD.

Keywords

References

  1. Yang BY, Lee NR, Son JM, Kang J, Sung EY, Song SH, et al. Factors Determining Renal Function in Korean Patients with Autosomal Dominant Polycystic Kidney Disease. The Korean Journal of Medicine 2010;78(2):207-14.
  2. Kim SW. Pathogenesis and New Treatment of Autosomal Dominant Polycystic Kidney Disease. The Korean Journal of Nephrology 2011;30(3) :231-8.
  3. Lim KH, Kim JS, Lee GH, Won JH, Shin GT, Kim HS, et al. Renal Artery Embolization in Patients with Polycystic Kidney Disease. The Korean Journal of Medicine 2015;88(4):453-8. https://doi.org/10.3904/kjm.2015.88.4.453
  4. Park HY, Hwang YH. Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease. The journal of Medicine 2015; 89(2):169-78.
  5. Bae HH, Lee JE, Han YJ, Lim DH, Park YC. A Case Study on Effect of No Mind-Therapy (Korean traditional Qigong) on Autosomal Dominant Polycystic Kidney Disease(ADPKD). The journal of internal Korean medicine 2004; 25(4):192-9.
  6. Choi IG, Cho CS, Kim CJ. Clinical Study on 1 Case of Patient with Adult Polycystic Kidney Disease. Journal of Haehwa Medicine 2005;14(1) :59-65.
  7. Ju AR, Ryu GH, Park MS, Choi YS, Choo WJ, Chae JW. A Case Report of Lumbar HIVD Treated with Korean Medicine on a Polycystic Kidney Patient. The Journal of Internal Korean Medicine 2020;41(2):132-40. https://doi.org/10.22246/jikm.2020.41.2.132
  8. Jiang BB. Clinical Study on Effect in Treating Polycystic Kidney Disease with the Method of San Jie Xiao Ji. Shandong University of Traditional Chinese Medicine 2013.
  9. 景艺雅. 活血消癥方治疗成人型多囊肾病的临床疗效观察[硕士]. 黑龙江中医药大学 2019.
  10. 邢璐. 加味桂枝茯苓丸治疗多囊肾病的临床疗效观察[硕士]. 黑龙江中医药大学 2018.
  11. 王铁民, 刘丙欣. 中药外用给药治疗多囊肾患者132例疗效观察. 中国中西医结合学会会议论文集 2010.
  12. 王瑞平, 薛闪, 施书芳, 曹西田, 刘维旭, 刘建, et al. 软坚散结活血行气法对肾功能不全代偿期及失代偿期的多囊肾患者的治疗效果研究. 世界中医药 2019;14(9):2387-91.
  13. 王春寒, 石伟, 张茜英, 贺艳光, 刁平, 杨启超. 肾区经穴敷熨对多囊肾囊肿的疗效观察. 安徽医药 2019;23(1):87-90.
  14. 李瑞玲, 杜霄壤, 丁世永, 黄迪, 何立群, 王琛, et al. 抑囊方治疗脾肾亏虚兼血瘀型多囊肾临床观察. 中国中西医结合肾病杂志 2016;17(8):682-5.
  15. 牛成林, 张孔雀. 自拟逐瘀化痰汤治疗痰瘀互结型多囊肾的临床疗效观察. 求医问药 2012;10(2):616-7.
  16. 曹希同, 孙春华, 李芬. 中药肾区渗透控制多囊肾病 (PKD)进展124例疗效观察. 中国医药指南 2008; 6(6):177-9.
  17. 王锋. 中西医结合治疗成人型多囊肾. 中原医刊 2003; 30(21):35.
  18. 吴洪龄, 吴霞. 愈囊消胶囊治疗多囊肾31例. 中医杂志 2002;43(1):47-8.
  19. 汪水君, 成焕忠. 中西医结合治疗成人性多囊肾13例临床分析. 贵州中医药大学学报 2001;23(1): 34-5.
  20. 袁明泽, 袁新珍, 袁明经. 针药并用治疗多囊肾12例. 北京中医药 2001;3:28.
  21. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. 18th ed. Vol. 2. New York: McGraw-Hill Medical; 2012, p. 2355-66.
  22. Yoder BK, Hou X, Guay-Woodford LM. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol 2002;13(10) :2508-16. https://doi.org/10.1097/01.ASN.0000029587.47950.25
  23. Kim HH, Namgoong H, Kim SJ, Ahn GR, Kang SM. Development of Microsatellite Markers for Diagnosis of Autosomal Dominant Polycystic Kidney Disease. Kidney Research and Clinical Practice 2000;19(4):674-80.
  24. Ubara Y, Tagami T, Sawa N, Katori H, Yokota M, Takemoto F, et al. Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. American Journal of Kidney Disease 2002;39(3) :571-9. https://doi.org/10.1053/ajkd.2002.31407
  25. Yoon JW, Kim SJ. The Effect of Gyejibokryunghwan on Fracture Union in Tibia-fractured Rats. Journal of Korean Medicine Rehabilitation 2019; 29(4):1-14. https://doi.org/10.18325/jkmr.2019.29.4.1
  26. Jung H, Park JO, Kim SY, Lee EJ, Oh MS. Review on the study of Gyejibokryeong-hwan - Had been published in Korea from 1990 to 2014. Journal of Haehwa Medicine 2015;24(1) :47-60.
  27. 焦安贵. 加味桂枝茯苓丸治疗糖尿病肾病30例临床观察. 四川中医 2014;8:102-3.
  28. 柳晓玲. 桂枝茯苓丸对糖尿病肾病的作用. 国外医学 2003;25(6):353.
  29. Kim SW, Keum DH, Lee MJ. Study on Corydalis Tuber for iontophoresis. Dongguk Journal of The Institute of Oriental Medicine 2000;8(2) :69-81.
  30. Kim MS, Kim JH, Youn DH, Jeong HW, Cho MR. Effects of Alismatis Rhizoma Pharmacopuncture at BL23 on Cisplatin-Induced Acute Renal Failure in Rats. Korean Journal of Acupuncture 2019;36(1):63-73. https://doi.org/10.14406/acu.2019.005
  31. Ryu MS, Yun YC, Kim JH. The Effect of Angelica gigas NAKAI Pharmacopuncture at ST(36) and BL(23) on Freund's Adjuvant Arthritis in Rats. Journal of Korean Acupuncture & Moxibustion Medicine Society 2010;27(5):25-34.
  32. Yun JJ, Lee HY, Lee HJ, Lee MS, Song HS, Park SY, et al. Comparison of Glomerular Filtration Rate Using Gates Method and Serum Creatinine. Korean journal of nuclear medicine technology 2009;13(3):66-6.
  33. Han KH, Han SY, Kang YS, Cha DR. Serum Cystatin C Concentration Compared with Serum Creatinine Concentration as a Marker of Glomerular Filtration Rate. Kidney Research and Clinical Practice 2006;25(5):737-44.
  34. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C-a new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998; 101(5):875-81. https://doi.org/10.1542/peds.101.5.875